Aeternum Capital AS invests in Carasent ASA Aeternum Capital AS has acquired 8.250 million shares in Carasent ASA. This corresponds to 15% of the votes and capital, which places Aeternum as the new largest shareholder. Aeternum is an alternative investment manager with a strategy to invest in public and private companies across the Nordic region. The main focus of the investment strategy is to apply an active ownership model to drive sustainable value creation in quality companies in the small and mid-cap segments. Through in-depth quantitative and qualitative analysis, Aeternum invests in public undervalued return expanders and overlooked industry leaders. - We have followed Carasent ASA for a period of time and they meet our criteria’s with profitable growth and an attractive business model in a highly attractive end market. Furthermore, the healthcare market is under structural change where digitalisation is a very strong trend, says Vegard Søraunet, Investment director at Aeternum. Carasent develops and delivers digital e-health services to over 500 customers and clinics in the private health care market in Scandinavia and has in recent years had an average growth of 40% per year. The company’s SaaS offering generates a high proportion of recurring revenue with over 100% net retention rates. The company’s strategy is to continue to develop and expand digitalization that helps customers to meet challenges in providing efficient and qualitative health care services. Going forward the strategy is based on three key foundations: geographical expansion, new market segments and an expanded product and service offering. - We are very pleased that Aeternum Capital AS chooses to invest in the company. This is a proof and approval of our long term work, comments Johan Lindqvist, Chairman of the Board of Carasent ASA. For further information contact: Johan Lindqvist, Chairman of the Board of Carasent ASA Cell: +46 733 550935 Vegard Søraunet, Investment Director Aeternum Capital AS Cell: +47 91 33 44 30
